nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
|
Subklewe, Marion |
|
|
204 |
C |
p. |
artikel |
2 |
A selective anatomically based lymph node sampling can replace a side specific pelvic lymphadenectomy in endometrial cancer with failed sentinel node mapping
|
Bollino, Michele |
|
|
204 |
C |
p. |
artikel |
3 |
COLUMBUS 7-year update: A randomized, open-label, phase III trial of encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF V600E/K-mutant melanoma
|
Schadendorf, Dirk |
|
|
204 |
C |
p. |
artikel |
4 |
Composite event-free-survival as an endpoint in oncology drug evaluation: Review and guidance perspectives from the Haute Autorité de Santé (HAS)
|
Lengliné, Etienne |
|
|
204 |
C |
p. |
artikel |
5 |
Corrigendum to “Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial” [Eur J Cancer 198 (2024) 113475]
|
Le Rhun, Emilie |
|
|
204 |
C |
p. |
artikel |
6 |
Editorial Board
|
|
|
|
204 |
C |
p. |
artikel |
7 |
EORTC QLQ-C30 normative data for the United Kingdom: Results of a cross-sectional survey of the general population
|
Young, Teresa |
|
|
204 |
C |
p. |
artikel |
8 |
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)
|
Kroese, Tiuri E. |
|
|
204 |
C |
p. |
artikel |
9 |
High serum sodium predicts immunotherapy response in metastatic renal cell and urothelial carcinoma
|
Klümper, Niklas |
|
|
204 |
C |
p. |
artikel |
10 |
Impact of immunosuppressive agents on the management of immune-related adverse events of immune checkpoint blockers
|
Cariou, Pierre-Louis |
|
|
204 |
C |
p. |
artikel |
11 |
Incomplete DPYD haplotype B3 in a patient with locally advanced gastric cancer: Reconsidering the 5-FU dosage strategy
|
Dierks, Sascha |
|
|
204 |
C |
p. |
artikel |
12 |
Letter Re: Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
Dai, Xiangyi |
|
|
204 |
C |
p. |
artikel |
13 |
N0 neck trial: Does intensification of follow-up (Ultrasound + Physical Examination) influence outcomes in early-stage oral cancer?
|
Vaish, Richa |
|
|
204 |
C |
p. |
artikel |
14 |
Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
|
Zwart, Wouter H. |
|
|
204 |
C |
p. |
artikel |
15 |
Real-world treatment patterns and medical costs of prostate cancer patients in Switzerland – A claims data analysis
|
Stucki, Michael |
|
|
204 |
C |
p. |
artikel |
16 |
Response to letter entitled: Re: Hepatocellular and extrahepatic cancers in non-alcoholic fatty liver disease: A systematic review and meta-analysis
|
Thomas, James A. |
|
|
204 |
C |
p. |
artikel |
17 |
Skin cancers are the most frequent cancers in fair-skinned populations, but we can prevent them.
|
Garbe, Claus |
|
|
204 |
C |
p. |
artikel |
18 |
Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma
|
Carril-Ajuria, Lucia |
|
|
204 |
C |
p. |
artikel |